Helius Medical Technologies, INC S-1 registration statements

Helius Medical Technologies, a neurotechnology company, has filed an S-1 registration statement for a public offering of common stock and warrants, seeking to raise approximately $13.6 million to address immediate financial needs and Nasdaq listing compliance, while facing substantial dilution for new investors.

Helius Medical Technologies is seeking to raise capital through a best efforts public offering of common stock, pre-funded warrants, and accompanying warrants.

Helius Medical Technologies is undertaking a best efforts public offering of common stock, warrants, and pre-funded warrants to raise capital for operations and working capital.